Affordable Access

The biology of the glutamatergic system and potential role in migraine

Master Publishing Group
Publication Date
  • Excitotoxicity
  • Familial Hemiplegic Migraine
  • Glutamate
  • Migraine With Aura
  • Migraine Without Aura
  • Neurotransmitters
  • Receptors
  • Transporters
  • 4 Aminobutyric Acid
  • Adx 10059
  • Ampa Receptor
  • Anticonvulsive Agent
  • Antimigraine Agent
  • Beta Adrenergic Receptor Blocking Agent
  • Calcium Channel Blocking Agent
  • Excitatory Amino Acid Transporter 1
  • Excitatory Amino Acid Transporter 2
  • Glutamate Receptor
  • Glutamic Acid
  • Kainic Acid Receptor
  • Ketamine
  • Memantine
  • N Methyl Dextro Aspartic Acid Receptor
  • Sodium Channel Nav1.1
  • Topiramate
  • Tricyclic Antidepressant Agent
  • Unclassified Drug
  • Amino Acid Transport
  • Ataxia
  • Atp1A2 Gene
  • Cacna1A Gene
  • Central Nervous System
  • Crystal Structure
  • Disease Activity
  • Drug Mechanism
  • Excitatory Amino Acid Transporter 1 Gene
  • Excitatory Amino Acid Transporter 2 Gene
  • Excitotoxicity
  • Familial Hemiplegic Migraine
  • Gene
  • Gene Expression Regulation
  • Genetic Association
  • Genetic Linkage
  • Genetic Risk
  • Genetic Variability
  • Glutamatergic System
  • Gria1 Gene
  • Gria3 Gene
  • Human
  • Kcnk18 Gene
  • Migraine
  • Missense Mutation
  • Mutational Analysis
  • Nerve Cell Necrosis
  • Nerve Excitability
  • Neuropathology
  • Neuroprotection
  • Neurotransmission
  • Nonhuman
  • Review
  • Rna Editing
  • Scn1A Gene
  • Single Nucleotide Polymorphism
  • Biology
  • Chemistry
  • Economics
  • Medicine


Migraine is a common genetically linked neurovascular disorder. Approximately ~12% of the Caucasian population are affected including 18% of adult women and 6% of adult men (1, 2). A notable female bias is observed in migraine prevalence studies with females affected ~3 times more than males and is credited to differences in hormone levels arising from reproductive achievements. Migraine is extremely debilitating with wide-ranging socioeconomic impact significantly affecting people's health and quality of life. A number of neurotransmitter systems have been implicated in migraine, the most studied include the serotonergic and dopaminergic systems. Extensive genetic research has been carried out to identify genetic variants that may alter the activity of a number of genes involved in synthesis and transport of neurotransmitters of these systems. The biology of the Glutamatergic system in migraine is the least studied however there is mounting evidence that its constituents could contribute to migraine. The discovery of antagonists that selectively block glutamate receptors has enabled studies on the physiologic role of glutamate, on one hand, and opened new perspectives pertaining to the potential therapeutic applications of glutamate receptor antagonists in diverse neurologic diseases. In this brief review, we discuss the biology of the Glutamatergic system in migraine outlining recent findings that support a role for altered Glutamatergic neurotransmission from biochemical and genetic studies in the manifestation of migraine and the implications of this on migraine treatment.

There are no comments yet on this publication. Be the first to share your thoughts.